Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma

Abstract

In metastatic RCC, SBRT produces promising LeC with minimal toxicity. Further study should be expanded beyond that of managing intracranial disease. Its selected use may delay the requirement for systemic therapies.